Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 56

1.

The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O'brien CP, Oslin DW, Lohoff FW, Berrettini WH.

Ann Hum Genet. 2014 Jan;78(1):33-9. doi: 10.1111/ahg.12046. Epub 2013 Nov 25.

2.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH.

Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20.

3.

Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, Ferraro TN, Hakonarson H, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Doyle GA, Lohoff FW, Berrettini WH.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):122-8. doi: 10.1016/j.drugalcdep.2012.06.023. Epub 2012 Jul 12.

4.

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.

Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Genes Brain Behav. 2012 Jun;11(4):415-23. doi: 10.1111/j.1601-183X.2012.00785.x. Epub 2012 Apr 11.

5.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, O'Brien CP.

J Subst Abuse Treat. 2012 Oct;43(3):303-12. doi: 10.1016/j.jsat.2011.12.014. Epub 2012 Feb 27.

6.

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.

Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Addict Biol. 2013 Jul;18(4):702-8. doi: 10.1111/j.1369-1600.2011.00346.x. Epub 2011 Jul 25.

7.

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O'Brien CP.

Am J Psychiatry. 2010 Jun;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852. Epub 2010 Mar 15.

8.

Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence.

Lohoff FW, Bloch PJ, Hodge R, Nall AH, Ferraro TN, Kampman KM, Dackis CA, O'Brien CP, Pettinati HM, Oslin DW.

Neurosci Lett. 2010 Apr 5;473(2):87-91. doi: 10.1016/j.neulet.2010.02.021. Epub 2010 Feb 17.

PMID:
20170711
9.

Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence.

Bloch PJ, Nall AH, Weller AE, Ferraro TN, Berrettini WH, Kampman KM, Pettinati HM, Dackis CA, O'Brien CP, Oslin DW, Lohoff FW.

Psychiatr Genet. 2009 Oct;19(5):275-6. doi: 10.1097/YPG.0b013e32832cec12. No abstract available.

10.

Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.

Lohoff FW, Bloch PJ, Ferraro TN, Berrettini WH, Pettinati HM, Dackis CA, O'Brien CP, Kampman KM, Oslin DW.

Neurosci Lett. 2009 Apr 10;453(3):199-203. doi: 10.1016/j.neulet.2009.02.026. Epub 2009 Feb 21.

11.

Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, Pettinati HM, Oslin DW, Dackis CA, O'Brien CP, Berrettini WH.

Neuropsychopharmacology. 2008 Dec;33(13):3078-84. doi: 10.1038/npp.2008.126. Epub 2008 Aug 13.

12.

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.

Lohoff FW, Bloch PJ, Weller AE, Nall AH, Doyle GA, Buono RJ, Ferraro TN, Kampman KM, Pettinati HM, Dackis CA, Oslin DW, O'Brien CP, Berrettini WH.

Neurosci Lett. 2008 Aug 8;440(3):280-3. doi: 10.1016/j.neulet.2008.05.073. Epub 2008 May 24.

13.

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Suh JJ, Dackis CA, Oslin DW, O'Brien CP.

J Subst Abuse Treat. 2008 Jun;34(4):378-90. Epub 2007 Jul 30.

14.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
15.

Does modafinil produce euphoria?

O'Brien CP, Dackis CA, Kampman K.

Am J Psychiatry. 2006 Jun;163(6):1109. No abstract available.

PMID:
16741217
16.

Clinical implications of cocaine-induced cortical depression.

Dackis CA, O'brien CP.

Neuropsychopharmacology. 2005 May;30(5):1033; author reply 1034-5. No abstract available.

17.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP.

Neuropsychopharmacology. 2005 Jan;30(1):205-11.

18.

Recent advances in the pharmacotherapy of cocaine dependence.

Dackis CA.

Curr Psychiatry Rep. 2004 Oct;6(5):323-31. Review.

PMID:
15355754
19.

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study.

Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O'Brien CP.

Drug Alcohol Depend. 2003 May 1;70(1):29-37.

PMID:
12681523
20.

Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients.

Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, O'Brien CP, Childress AR.

Biol Psychiatry. 2002 Jan 15;51(2):134-42.

PMID:
11822992
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk